(BCS) Barclays - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US06738E2046
Stock: Banking, Lending, Investments, Wealth Management
Total Rating 41
Risk 36
Buy Signal -0.97
| Risk 5d forecast | |
|---|---|
| Volatility | 44.0% |
| Relative Tail Risk | 3.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.08 |
| Alpha | 19.74 |
| Character TTM | |
|---|---|
| Beta | 1.073 |
| Beta Downside | 1.279 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.08% |
| CAGR/Max DD | 1.84 |
EPS (Earnings per Share)
Revenue
Description: BCS Barclays March 05, 2026
Barclays PLC (BCS) is a UK-headquartered diversified bank offering a broad range of financial services globally.
The companys operations span retail banking, wholesale banking, investment banking, and wealth management across segments like Barclays UK and Barclays Investment Bank. Diversified banks typically generate revenue from both interest-bearing assets and fee-based services.
Key offerings include current and savings accounts, mortgages, credit cards, and lending products. The financial services sector is highly regulated, impacting capital requirements and operational compliance.
Further research on ValueRay can provide deeper insights into BCSs performance metrics.
Headlines to watch out for
- Interest rate hikes boost net interest income
- Global economic slowdown impacts investment banking revenue
- Regulatory fines increase operating expenses
- UK economic stability affects retail banking performance
- Geopolitical events influence trading desk profitability
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 7.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -0.89 > 1.0 |
| NWC/Revenue: -1032 % < 20% (prev -613.8%; Δ -417.9% < -1%) |
| CFO/TA 0.03 > 3% & CFO 39.04b > Net Income 7.17b |
| Net Debt (-58.99b) to EBITDA (9.71b): -6.08 < 3 |
| Current Ratio: 0.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.47b) vs 12m ago -9.09% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 1.83% > 50% (prev 1.66%; Δ 0.18% > 0%) |
| Interest Coverage Ratio: -0.31 > 6 (EBITDA TTM 9.71b / Interest Expense TTM 21.21b) |
Altman Z'' -1.08
| A: -0.19 (Total Current Assets 407.84b - Total Current Liabilities 697.65b) / Total Assets 1544.16b |
| B: 0.04 (Retained Earnings 59.25b / Total Assets 1544.16b) |
| C: -0.00 (EBIT TTM -6.53b / Avg Total Assets 1531.18b) |
| D: 0.05 (Book Value of Equity 77.07b / Total Liabilities 1465.93b) |
| Altman-Z'' Score: -1.08 = CCC |
Beneish M
| DSRI: none (Receivables 276.0m/none, Revenue 28.09b/25.14b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.11 (AQ_t 0.73 / AQ_t-1 0.66) |
| SGI: 1.12 (Revenue 28.09b / 25.14b) |
| TATA: -0.02 (NI 7.17b - CFO 39.04b) / TA 1544.16b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BCS shares?
As of March 09, 2026, the stock is trading at USD 21.86 with a total of 8,360,537 shares traded.
Over the past week, the price has changed by -7.80%, over one month by -17.18%, over three months by -4.89% and over the past year by +50.80%.
Over the past week, the price has changed by -7.80%, over one month by -17.18%, over three months by -4.89% and over the past year by +50.80%.
Is BCS a buy, sell or hold?
Barclays has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy BCS.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.4 | 25.3% |
| Analysts Target Price | 27.4 | 25.3% |
BCS Fundamental Data Overview March 05, 2026
Market Cap GBP = 60.24b (80.55b USD * 0.7479 USD.GBP)
P/E Trailing = 10.163
P/E Forward = 8.0972
P/S = 3.0036
P/B = 0.7786
P/EG = 1.3493
Revenue TTM = 28.09b GBP
EBIT TTM = -6.53b GBP
EBITDA TTM = 9.71b GBP
Long Term Debt = 131.99b GBP (from longTermDebt, last quarter)
Short Term Debt = 73.13b GBP (from shortTermDebt, last quarter)
Debt = 170.76b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -58.99b GBP (from netDebt column, last quarter)
Enterprise Value = -176.56b GBP (60.24b + Debt 170.76b - CCE 407.56b)
Interest Coverage Ratio = -0.31 (Ebit TTM -6.53b / Interest Expense TTM 21.21b)
EV/FCF = 21.88x (Enterprise Value -176.56b / FCF TTM -8.07b)
FCF Yield = 4.57% (FCF TTM -8.07b / Enterprise Value -176.56b)
FCF Margin = -28.73% (FCF TTM -8.07b / Revenue TTM 28.09b)
Net Margin = 25.53% (Net Income TTM 7.17b / Revenue TTM 28.09b)
Gross Margin = unknown ((Revenue TTM 28.09b - Cost of Revenue TTM 528.0m) / Revenue TTM)
Tobins Q-Ratio = -0.11 (set to none) (Enterprise Value -176.56b / Total Assets 1544.16b)
Interest Expense / Debt = 12.42% (Interest Expense 21.21b / Debt 170.76b)
Taxrate = 20.87% (388.0m / 1.86b)
NOPAT = -5.17b (EBIT -6.53b * (1 - 20.87%)) [loss with tax shield]
Current Ratio = 0.58 (Total Current Assets 407.84b / Total Current Liabilities 697.65b)
Debt / Equity = 2.20 (Debt 170.76b / totalStockholderEquity, last quarter 77.78b)
Debt / EBITDA = -6.08 (Net Debt -58.99b / EBITDA 9.71b)
Debt / FCF = 7.31 (negative FCF - burning cash) (Net Debt -58.99b / FCF TTM -8.07b)
Total Stockholder Equity = 76.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.17b / Total Assets 1544.16b)
RoE = 9.41% (Net Income TTM 7.17b / Total Stockholder Equity 76.24b)
RoCE = -3.14% (EBIT -6.53b / Capital Employed (Equity 76.24b + L.T.Debt 131.99b))
RoIC = -2.37% (negative operating profit) (NOPAT -5.17b / Invested Capital 218.27b)
WACC = 9.84% (E(60.24b)/V(231.01b) * Re(9.87%) + D(170.76b)/V(231.01b) * Rd(12.42%) * (1-Tc(0.21)))
Discount Rate = 9.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -52.04%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 24.15 | EPS CAGR: -0.85% | SUE: -0.02 | # QB: 0
Revenue Correlation: 30.40 | Revenue CAGR: 0.01% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.79 | Chg7d=-0.014 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.97 | Chg7d=+0.044 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+27.7% | Growth Revenue=+5.8%
EPS next Year (2027-12-31): EPS=3.55 | Chg7d=+3.553 | Chg30d=+3.553 | Revisions Net=+0 | Growth EPS=+19.7% | Growth Revenue=+4.3%
P/E Trailing = 10.163
P/E Forward = 8.0972
P/S = 3.0036
P/B = 0.7786
P/EG = 1.3493
Revenue TTM = 28.09b GBP
EBIT TTM = -6.53b GBP
EBITDA TTM = 9.71b GBP
Long Term Debt = 131.99b GBP (from longTermDebt, last quarter)
Short Term Debt = 73.13b GBP (from shortTermDebt, last quarter)
Debt = 170.76b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = -58.99b GBP (from netDebt column, last quarter)
Enterprise Value = -176.56b GBP (60.24b + Debt 170.76b - CCE 407.56b)
Interest Coverage Ratio = -0.31 (Ebit TTM -6.53b / Interest Expense TTM 21.21b)
EV/FCF = 21.88x (Enterprise Value -176.56b / FCF TTM -8.07b)
FCF Yield = 4.57% (FCF TTM -8.07b / Enterprise Value -176.56b)
FCF Margin = -28.73% (FCF TTM -8.07b / Revenue TTM 28.09b)
Net Margin = 25.53% (Net Income TTM 7.17b / Revenue TTM 28.09b)
Gross Margin = unknown ((Revenue TTM 28.09b - Cost of Revenue TTM 528.0m) / Revenue TTM)
Tobins Q-Ratio = -0.11 (set to none) (Enterprise Value -176.56b / Total Assets 1544.16b)
Interest Expense / Debt = 12.42% (Interest Expense 21.21b / Debt 170.76b)
Taxrate = 20.87% (388.0m / 1.86b)
NOPAT = -5.17b (EBIT -6.53b * (1 - 20.87%)) [loss with tax shield]
Current Ratio = 0.58 (Total Current Assets 407.84b / Total Current Liabilities 697.65b)
Debt / Equity = 2.20 (Debt 170.76b / totalStockholderEquity, last quarter 77.78b)
Debt / EBITDA = -6.08 (Net Debt -58.99b / EBITDA 9.71b)
Debt / FCF = 7.31 (negative FCF - burning cash) (Net Debt -58.99b / FCF TTM -8.07b)
Total Stockholder Equity = 76.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 7.17b / Total Assets 1544.16b)
RoE = 9.41% (Net Income TTM 7.17b / Total Stockholder Equity 76.24b)
RoCE = -3.14% (EBIT -6.53b / Capital Employed (Equity 76.24b + L.T.Debt 131.99b))
RoIC = -2.37% (negative operating profit) (NOPAT -5.17b / Invested Capital 218.27b)
WACC = 9.84% (E(60.24b)/V(231.01b) * Re(9.87%) + D(170.76b)/V(231.01b) * Rd(12.42%) * (1-Tc(0.21)))
Discount Rate = 9.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -52.04%
[DCF] Fair Price = unknown (Cash Flow -8.07b)
EPS Correlation: 24.15 | EPS CAGR: -0.85% | SUE: -0.02 | # QB: 0
Revenue Correlation: 30.40 | Revenue CAGR: 0.01% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.79 | Chg7d=-0.014 | Chg30d=-0.015 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=2.97 | Chg7d=+0.044 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+27.7% | Growth Revenue=+5.8%
EPS next Year (2027-12-31): EPS=3.55 | Chg7d=+3.553 | Chg30d=+3.553 | Revisions Net=+0 | Growth EPS=+19.7% | Growth Revenue=+4.3%